Philips strikes R&D pact

Article

Philips Medical Systems and Theseus Imaging, a subsidiary of North American Scientific, have agreed to collaborate on research aimed at improving methodology for the noninvasive imaging of cardiac cell

Philips Medical Systems and Theseus Imaging, a subsidiary of North American Scientific, have agreed to collaborate on research aimed at improving methodology for the noninvasive imaging of cardiac cell death.

The two companies hope to optimize techniques and instrumentation for using Apomate, an investigational in vivo nuclear medicine imaging agent that targets cells undergoing apoptosis or necrosis. Theseus will provide images and other data from its cardiac imaging trials of Apomate to Philips. Apomate images will be fused with images taken using thallium. The collaboration may result in methods that enhance Apomate imaging, leading to increased clinical acceptance and improved clinical outcomes when Apomate imaging is applied.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.